March 12, 2012
Sosei Group Corporation announced on March 8 that its wholly owned subsidiary, Sosei Co. Ltd. (Chiyoda-ku, Tokyo), had initiated PI clinical trials for its oropharyngeal candidiasis treatment SO-1105. The study will be conducted with healthy Japanese adults at domestic medical...read more